Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data

被引：0
|
作者：
Hirohito Shimizu
Hisanori Kobayashi
Masayoshi Kanbori
Yutaka Ishii
机构：
[1] Janssen Pharmaceutical K.K,Medical Affairs Division, Immunology Department
[2] R&D Janssen Pharmaceutical K.K.,Clinical Science Division, External Collaboration and Portfolio Management Department
[3] Janssen Pharmaceutical K.K.,Japan Safety & Surveillance Division, Research & Development Division
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Dose escalation; Golimumab; Post-marketing surveillance; Real-world evidence; Rheumatoid arthritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 325
页数：14
相关论文
共 50 条
  • [41] Impact of gender on outcome of Japanese patients with rheumatoid arthritis: The post marketing surveillance trial.
    Dabbous, O.
    Rahman, M. I.
    Gilmer, K.
    Yano, T.
    Nogami, Y.
    Arjunji, R.
    Thompson, H.
    Tang, B.
    Takeuchi, T.
    Koike, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S55 - S55
  • [42] Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance
    Harigai, Masayoshi
    Ishiguro, Naoki
    Inokuma, Shigeko
    Mimori, Tsuneyo
    Ryu, Junnosuke
    Takei, Syuji
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takasaki, Yoshinari
    Yamanaka, Hisashi
    Yoshizawa, Yuri
    Chineni, Ichino
    Nakao, Toru
    Koike, Takao
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 747 - 755
  • [43] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2023, 33 (03) : 460 - 471
  • [44] POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS
    LEWIS, JA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (04) : 93 - 94
  • [45] Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance
    Uhara, Hisashi
    Tsuchida, Tetsuya
    Kiyohara, Yoshio
    Akamatsu, Ayumi
    Sakamoto, Takahiko
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : 862 - 871
  • [46] Post-marketing surveillance of carfilzomib in Japanese patients with relapsed or refractory multiple myeloma
    Kawasaki, Akira
    Murakami, Hirokazu
    Chou, Takaaki
    Matsushita, Masaru
    Kizaki, Masahiro
    FUTURE ONCOLOGY, 2022, 18 (24) : 2661 - 2674
  • [47] A JAPANESE POST-MARKETING SURVEILLANCE OF REGORAFENIB IN COLORECTAL CANCER PATIENTS: INTERIM REPORT
    Satoh, Taroh
    Yamazaki, Naoya
    Takikawa, Hajime
    Ito, Hideyuki
    Ito, Yuichiro
    Sakaguchi, Toshiaki
    Yamada, Takashi
    Muro, Kei
    Sugihara, Kenichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [48] A Japanese Post-marketing Surveillance of Cetuximab (Erbitux) in Patients with Metastatic Colorectal Cancer
    Ishiguro, Megumi
    Watanabe, Toshiaki
    Yamaguchi, Kensei
    Satoh, Taroh
    Ito, Hideyuki
    Seriu, Taku
    Sakata, Yuh
    Sugihara, Kenichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (04) : 287 - 294
  • [49] Real-world experience with eculizumab in Japanese patients with myasthenia gravis: Post-marketing surveillance data
    Takahashi, M.
    Masuda, M.
    Watanabe, M.
    Fukamizu, Y.
    Osawa, T.
    Kikui, H.
    Murai, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 574 - 574
  • [50] Safety and effectiveness of secukinumab subcutaneous injection in Japanese patients with psoriasis vulgaris and psoriatic arthritis: A post-marketing surveillance
    Fujishige, Ayako
    Seko, Noriko
    JOURNAL OF DERMATOLOGY, 2025, 52 (01): : 11 - 23
12345